The Lyme disease vaccine: Implications for Bell palsy

Infections in Medicine

Volumn 17, Issue 6, 2000, Pages 456-457

  Oransky, Ivan ^a   Saraiya, Ankur ^b,c  

^a YALE NEW HAVEN HOSPITAL   (United States)

^b College of Physicians and Surgeons ^*  (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Bell palsy; Lyme disease

Indexed keywords

LYME DISEASE VACCINE; OUTER MEMBRANE PROTEIN;

ARTICLE; BELL PALSY; BORRELIA BURGDORFERI; BORRELIA INFECTION; DRUG EFFICACY; FOOD AND DRUG ADMINISTRATION; HUMAN; LYME DISEASE;

EID: 0033918560     PISSN: 07496524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Williams CL, Curran AS, Lee AC, Sousa VO. Lyme disease: epidemiologic characteristics of an outbreak in Westchester County, NY. Am J Public Health. 1986;76:62-65.
2. Belman AL, Iyer M, Coyle PK, et al. Neurologic manifestations in children with North American Lyme disease. Neurology. 1993;43:2609-2614.
3. Jonsson L, Stiernstedt G, Thomander L. Tick-born Borrelia infection in patients with Bell's palsy. Arch Otolaryngol Head Neck Surg. 1987; 113:303-306.
4. Kuiper H, Devriese P, Bartelt M, et al. Absence of Lyme borreliosis among patients with presumed Bell's palsy. Arch Neurol. 1992;49:940-943.
5. Ikeda M, Kawabata M, Kuga M, Nakazato H. Anti-Borrelia burgdorferi antibodies in patients with facial paralysis. Eur Arch Otorhinolaryngol. 1993;249:488-491.
6. Strle F, Nadelman RB, Cimperman J, et al. Comparison of culture-confirmed erythema migrans caused by Borrelia burgdorferi sensu stricto in New York State and by Borrelia afzelii in Slovenia. Ann Intern Med. 1999;130:32-36.
7. Altman LK. Lyme vaccine is approved, with caveat. New York Times. December 22, 1998:A20.
8. Steere AC, Sikand VK, Meurice F, et al. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group. N Engl J Med. 1998;339:209-215.
9. Sigal LH, Zahradnik JM, Lavin P, et al. A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium. N Engl J Med. 1998;339:216-222.
10. Meurice F, Parenti D, Fu D, Krause DS. Specific issues in the design and implementation of an efficacy trial for a Lyme disease vaccine. Clin Infect Dis. 1997;25:S71-S75.
11. Steigbigel RT, Benach JL. Immunization against Lyme disease - an important first step. N Engl J Med. 1998;339:263-264.
12. Peltomaa M, Saxen H, Seppala I, et al. Paediatric facial paralysis caused by Lyme borreliosis: a prospective and retrospective analysis. Scand J Infect Dis. 1998;30:269-275.
13. Cook S, Macartney K, Rose C, et al. Lyme disease and seventh nerve paralysis in children. Am J Otolaryngol. 1997;18:320-323.
14. Christen HJ, Bartlau N, Hanefeld F, et al. Peripheral facial palsy in childhood - Lyme borreliosis to be suspected unless proven otherwise. Acta Paediatr Scand. 1990;79:1219-1224.